Description
Product details
GLICLAGLAZE 80 Gliclazide (80mg) Overview GLICLAGLAZE 80 is a medication containing 80 milligrams of Gliclazide, an oral hypoglycemic agent used primarily in the management of type 2 diabetes mellitus. As a sulfonylurea, Gliclazide works by stimulating the release of insulin from the pancreatic beta cells, thereby helping to control blood glucose levels. Uses Type 2 Diabetes Mellitus: GLICLAGLAZE 80 is prescribed for patients with type 2 diabetes who cannot manage their condition through diet and exercise alone. It helps in lowering blood sugar levels, thereby reducing the risk of diabetes-related complications. Secondary Failure of Metformin: It is often used when other first-line treatments, such as Metformin, fail to adequately control blood sugar levels. Dosage and Administration Individualized Treatment: The dosage of GLICLAGLAZE 80 is individualized based on the patient’s blood glucose response. It is typically started at a lower dose and gradually increased. Administration: It is usually taken once or twice daily with meals to enhance absorption and reduce the risk of gastrointestinal side effects. Consistent timing of doses each day helps maintain stable blood glucose levels. Adjustments: Dosage adjustments are made based on regular monitoring of blood glucose levels and glycosylated hemoglobin (HbA1c). Mechanism of Action Gliclazide works by binding to specific receptors on the pancreatic beta cells, leading to the closure of potassium channels and the opening of calcium channels. This action results in an influx of calcium ions, which stimulates the secretion of insulin. Increased insulin levels help to lower blood glucose levels by facilitating the uptake of glucose by tissues and inhibiting glucose production by the liver. Side Effects Common Side Effects: These include hypoglycemia (low blood sugar), dizziness, headache, nausea, and gastrointestinal disturbances such as abdominal pain and diarrhea. Serious Side Effects: Although rare, serious side effects may include severe hypoglycemia, liver function abnormalities, and blood disorders such as thrombocytopenia and leukopenia. Immediate medical attention is required if these occur. Allergic Reactions: Allergic reactions to Gliclazide are rare but can include rash, itching, swelling, and difficulty breathing. Discontinue use and seek medical attention if these symptoms occur. Precautions Medical History: Inform your doctor about your complete medical history, especially if you have liver or kidney disease, adrenal or pituitary insufficiency, or G6PD deficiency. Pregnancy and Breastfeeding: Gliclazide is not recommended during pregnancy or breastfeeding. Insulin therapy is usually preferred in these cases. Drug Interactions: Gliclazide may interact with other medications, such as beta-blockers, antifungal agents, and corticosteroids. Always inform your healthcare provider about all the medications and supplements you are taking. Alcohol: Avoid excessive alcohol consumption as it can enhance the blood sugar-lowering effect of Gliclazide and increase the risk of hypoglycemia. Monitoring Regular monitoring of blood glucose levels is crucial for patients taking GLICLAGLAZE 80. Periodic testing of HbA1c provides an indication of long-term glucose control. Routine checks of liver and kidney function tests are also recommended to ensure the safe use of the medication. Conclusion GLICLAGLAZE 80, containing 80 mg of Gliclazide, is an effective medication for managing type 2 diabetes mellitus. By stimulating insulin secretion, it helps control blood glucose levels, thereby reducing the risk of complications associated with diabetes. Proper dosing, regular monitoring, and adherence to prescribed treatment plans are essential for achieving optimal therapeutic outcomes. Consult your healthcare provider for personalized advice and adjustments to your treatment regimen. For further information Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 BUY NOW